# STOX1

## Overview
STOX1, or storkhead box 1, is a gene that encodes a transcription factor protein involved in various cellular processes, particularly in placental development and cell cycle regulation. The protein, characterized by a winged-helix DNA-binding domain, plays a crucial role in modulating gene expression by binding to specific DNA sequences. As a transcription factor, storkhead box 1 is integral to the regulation of trophoblast invasion, a process essential for proper placental function, and is implicated in conditions such as preeclampsia due to its influence on cell adhesion and epithelial-mesenchymal transition (van2010The). Additionally, STOX1 is involved in the PI3K/Akt signaling pathway, affecting cell proliferation, migration, and apoptosis (Li2018Effect). Its clinical significance extends to its role as a tumor suppressor in glioma, where its downregulation is associated with poor prognosis (Jin2021Downregulation). The gene's activity and the protein's interactions underscore its importance in both normal physiological processes and disease states.

## Structure
STOX1 (storkhead box 1) is a transcription factor characterized by a winged-helix DNA-binding domain. The primary structure of STOX1 consists of a sequence of amino acids encoded by the STOX1 gene. This sequence forms the basis for its secondary structures, which may include alpha helices and beta sheets. The tertiary structure of STOX1 refers to its overall three-dimensional shape, which is crucial for its function as a transcription factor. The quaternary structure involves the assembly of multiple protein subunits, if applicable, although specific details on this aspect are not provided.

STOX1 may undergo post-translational modifications, which can influence its function and localization within the cell. These modifications are essential for the regulation of its activity and interaction with other cellular components. Additionally, splice variant isoforms of STOX1 can exist, potentially leading to variations in its structure and function. These isoforms may result from alternative splicing events, which can produce proteins with different properties and roles in cellular processes. The presence of these isoforms highlights the complexity and versatility of STOX1 in its regulatory functions.

## Function
STOX1 is a transcription factor that plays a significant role in regulating gene expression, particularly in the context of placental development. It is involved in the regulation of trophoblast invasion, a critical process for proper placental function. STOX1 influences this process by modulating the expression of α-T-catenin, a component of the cell-cell adhesion complex, which affects the epithelial-mesenchymal transition of trophoblasts (van2010The). The gene's activity is allele-dependent, with specific alleles like the Y153H variant being associated with reduced trophoblast invasion, potentially impacting conditions such as pre-eclampsia (van2010The).

STOX1 is also involved in the PI3K/Akt signaling pathway, which is crucial for cell cycle regulation, proliferation, and apoptosis. It has been shown to regulate the expression of proteins such as pAKT and p85, thereby influencing trophoblast cell proliferation and migration (Li2018Effect). In healthy human cells, STOX1 is primarily active in the nucleus, where it binds to DNA to modulate transcription, impacting cellular processes like differentiation and development (Jin2021Downregulation). Its role in oxidative stress regulation and potential involvement in other cellular pathways, such as the Wnt signaling pathway, further highlight its importance in cell biology (Jin2021Downregulation).

## Clinical Significance
STOX1 has been implicated in several clinical conditions, most notably preeclampsia and glioma. In preeclampsia, a pregnancy-related disorder characterized by high blood pressure and potential organ damage, STOX1 is associated with reduced trophoblast invasion due to the upregulation of α-T-catenin, a cell adhesion protein. This regulation is crucial during the epithelial-mesenchymal transition of trophoblasts, a key process in early pregnancy (van2010The). The Y153H variant of STOX1 is a common missense variant linked to preeclampsia susceptibility, although its presence is not necessarily deleterious (Parchem2021STOX1). STOX1's role in preeclampsia is further supported by its involvement in the renin-angiotensin system, where its deficiency leads to gestational hypertension (Parchem2021STOX1).

In glioma, STOX1 is downregulated in high-grade tumors and serves as an independent predictor of poor prognosis. It functions as a tumor suppressor, with its downregulation linked to worse outcomes in glioma patients. STOX1 is involved in critical pathways such as p53 signaling, DNA replication, and cell cycle regulation, which are essential in cancer progression (Jin2021Downregulation). These findings suggest STOX1's potential as a prognostic biomarker and its impact on treatment efficacy in glioma (Jin2021Downregulation).

## Interactions
STOX1 is a transcription factor that participates in various interactions with proteins and nucleic acids, influencing cellular processes. It has been shown to directly bind to the promoter region of the CCNB1 gene, regulating cell cycle progression and mitotic entry. This interaction is crucial for the transition into mitosis, as evidenced by chromatin immunoprecipitation assays that demonstrate STOX1A's binding to the CCNB1 promoter (van2012Transcription).

STOX1 also interacts with the PI3K/Akt signaling pathway, which is important for cell proliferation, migration, and apoptosis. In trophoblast cells, STOX1 regulates the expression of pAKT and p85 proteins, thereby influencing these cellular processes. Knockdown of STOX1 results in decreased expression of these proteins, while overexpression enhances their levels, promoting cell proliferation and migration (Li2018Effect).

In the context of pulmonary arterial hypertension, STOX1 overexpression in pulmonary artery smooth muscle cells leads to increased cell proliferation and migration, mediated through the AKT signaling pathway. This interaction is associated with the upregulation of cell cycle-related proteins such as PCNA, Cyclin E, and Cyclin A (Xu2019Stox1).


## References


[1. (van2012Transcription) Daan van Abel, Omar Abdul-Hamid, Marie van Dijk, and Cees B. M. Oudejans. Transcription factor stox1a promotes mitotic entry by binding to the ccnb1 promotor. PLoS ONE, 7(1):e29769, January 2012. URL: http://dx.doi.org/10.1371/journal.pone.0029769, doi:10.1371/journal.pone.0029769. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0029769)

[2. (Jin2021Downregulation) Fei-qin Jin, Lei Jin, and Yan-ling Wang. Downregulation of stox1 is a novel prognostic biomarker for glioma patients. Open Life Sciences, 16(1):1164–1174, January 2021. URL: http://dx.doi.org/10.1515/biol-2021-0119, doi:10.1515/biol-2021-0119. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/biol-2021-0119)

[3. (Li2018Effect) Zhifang Li, Guiju Zhou, Longfan Jiang, Huifen Xiang, and Yunxia Cao. Effect of stox1 on recurrent spontaneous abortion by regulating trophoblast cell proliferation and migration via the pi3k/akt signaling pathway. Journal of Cellular Biochemistry, 120(5):8291–8299, December 2018. URL: http://dx.doi.org/10.1002/jcb.28112, doi:10.1002/jcb.28112. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.28112)

[4. (Xu2019Stox1) Yi Xu, Zengxian Sun, Qian Wang, Tianyan Wang, Yun Liu, and Feng Yu. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via akt signaling pathway. Vascular Pharmacology, 120:106568, September 2019. URL: http://dx.doi.org/10.1016/j.vph.2019.106568, doi:10.1016/j.vph.2019.106568. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.vph.2019.106568)

[5. (Parchem2021STOX1) Jacqueline G. Parchem, Keizo Kanasaki, Soo Bong Lee, Megumi Kanasaki, Joyce L. Yang, Yong Xu, Kadeshia M. Earl, Rachel A. Keuls, Vincent H. Gattone, and Raghu Kalluri. Stox1 deficiency is associated with renin-mediated gestational hypertension and placental defects. JCI Insight, January 2021. URL: http://dx.doi.org/10.1172/jci.insight.141588, doi:10.1172/jci.insight.141588. This article has 6 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1172/jci.insight.141588)

[6. (van2010The) Marie van Dijk, Jan van Bezu, Daan van Abel, Caroline Dunk, Marinus A. Blankenstein, Cees B.M. Oudejans, and Stephen J. Lye. The stox1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by α-t-catenin upregulation. Human Molecular Genetics, 19(13):2658–2667, April 2010. URL: http://dx.doi.org/10.1093/hmg/ddq152, doi:10.1093/hmg/ddq152. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddq152)